• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities Product Image

06 - 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

  • ID: 2191572
  • June 2012
  • 40 Pages
  • Life Science Intelligence

This report includes details on 39 emerging medical technology companies that have been identified by LSI's in-house research team in June 2012.

All companies include technology, market(s), key executive, and contact information.

Two- to three-page executive summaries are provided on most of the companies.

Executive summaries typically include:

- Company Contact Information
- Company Overview (structure, size, year founded, etc.)
- Competitive Landscape
- Technological Advantage
- Stage of Development
- Target Markets
- Financial Summary and Sales Forecasts
- Financing & Partnering Needs
- IP Position & Status
- Management Team
- Exit Strategy
- More

Coverage includes innovations in a broad spectrum of medical technology areas including:

- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companies
- Drug Delivery Companies
- Endocrine Companies
- Gastroenterology Companies
- Gynecology/Women's Health Companies
- Imaging Companies
- Neurology Companies
- Oncology Companies
- Ophthalmology Companies
- Orthopedics Companies
- Pain Management Companies
- Patient Management/Monitoring Companies
- Pharmaceutical Companies
- Respiratory Companies
- Spine Companies
- Surgery Companies
- Urology Companies
- Vascular Companies
- Wound Management Companies

- The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as well as a disposable device that maximizes contact with the fluid or blood

- A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells

- The Hemolung Respiratory Assist System, a respiratory dialysis product comprising a contoller, cartridge, and catheter; intended to replace or supplement mechanical ventilation in Intensive Care Unit (ICU) patients with acute hypercapnic respiratory failure

- Nanotechnology-based Point-of-Care products for the collection and screening of blood, urine, or oral fluids

- 1. Vascular staplers for open surgery of abdominal aortic aneurysms (AAAs) or aorto-biliac/femoral bypasses 2. Endovascular staplers for fixation of any current stent-grafts 3. Staplers for Critical Limb Ischemia surgery, aiming to replace Femoro-Popliteal bypasses

- Ultrasound-guided cryothermally enhanced devices used to facilitate the site-specific C(2) (Cryo-Chemo) Cancer Ablation Procedure, which delivers newly developed proprietary therapies to cancer sites while avoiding toxic side effects

- A three-layered biological patch, called the LeucoPatch, which can be derived without additives from the patient's blood within 20 minutes; used for chronically non-healing and debilitating wounds

- The ViSi Mobile System, a comprehensive vital signs monitoring platform for bedside, ambulatory, or transport applications

- The CoolTools family of products, which target support/microcatheterization, local vascular drug delivery, and selective hypothermia for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma)

- Intraurethral devices including a prostatic urethral stent and a urethral measurement device to enable the selection of proper stent sizes

- Biological therapies targeting bone loss, blood and muscular weakness disorders, cancer, and rheumatoid arthritis

- Corneal inlay for the treatment of near vision loss

- Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2

- Therapeutic antibodies discovered and optimized using somatic hypermutation (SHM)

- Offers technologies for drug delivery systems, including complex release products, fast-dispersing dosage forms, and biodegradable polymers for custom release profiles in implants

- Targeted nanoparticles that selectively accumulate at disease sites and minimize the damage to healthy tissues for the treatment of cancer, cardiovascular conditions, and inflammatory diseases

- Develops polymer composite products for biomedical applications, including clear braces for orthodontic patients

- A continuous glucose monitoring device

- Diagnostic assays for joint fluid analysis; these technologies use a lateral flow immunoassay designs and are used to rapidly detect the causes of joint pain

- An electrical stimulation device that targets the weak/dysfunctional lower esophageal sphincter in order to treat severe Gastro Esophageal Reflux Disease (GERD)

- A glaucoma-detection technology that superimposes images of the posterior pole of the eye to show changes over time

- Portable oxygen concentrator for active respiratory patients

- Microfluidic automation systems used for rapid DNA analysis

- A neurostimulation device for the treatment of lower back pain

- A highly-articulated multi-link robot that enables the performance of minimally invasive surgery

- Discreet sensors placed throughout the home for the purpose of monitoring elderly individuals

- Innovative protein, peptide, and antibody drug candidates for the treatment of cardiovascular disease, diabetes, muscle wasting, and obesity

- Lenses that address vision problems associated with higher-order aberrations of the eye, improving vision, contrast acuity, nighttime driving vision, and color dullness

- Innovative therapeutics for cardiovascular disease and autoimmune/inflammatory diseases that are based on targets with established proof of concept and can offer advantages over existing therapies

- A pain management patch comprising a dressing and skin-friendly adhesive

- Orthopedic devices

- A cost-effective, efficient system for the production of ophthalmic lenses

- New antibacterial drugs that target multi-drug resistant pathogens

- Low-cost, portable ultrasound systems that offer bone and 3D imaging capabilities

- A fully-implantable continuous glucose monitoring system that utilizes fluorescence sensing technology

- Orthopedic plate and screw systems for large and small bone fragments

- A novel, short-peripheral intravenous (IV) catheter featuring a pre-assembled, closed design with high-pressure extension tubing, a multi-use flow control clamp, and stabilization technology

- Portable x-ray technologies for medical applications

- External radiation therapy technology

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos